William K. Mcvicar serves as Executive at Salarius Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, William K. Mcvicar has executed 3 insider transactions totaling $15.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 3, 2023 involved receiving (via award) 1,440 shares valued at $0.
William K. Mcvicar currently holds 1,788 shares of Salarius Pharmaceuticals, Inc. (SLRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William K. Mcvicar has been a net buyer of SLRX stock. They have purchased $15.1K and sold $0 worth of shares.
William K. Mcvicar's most recent insider trade was on Jan 3, 2023, when they sold 1,440 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.19 |
| Discretionary |
| Feb 11, 2020 | SLRX | $10.0K | Purchase | 8,700 | $1.15 | Discretionary |